Molecular retention mechanisms of the G1 cyclin/Cdk complex in budding yeast

Budding yeast (Saccharomyces cerevisiae) cells coordinate cell growth and cell cycle progression essentially during G1, where they must reach a critical cell size to traverse Start and enter the cell cycle. The most upstream activator of Start is Cln3, a G1 cyclin that together with the cyclin-dependent kinase Cdc28 triggers a transcriptional wave that drives cell cycle entry. The Cln3 cyclin is a low abundant and very unstable protein whose levels respond very rapidly to nutritional changes. However, Cln3 expression is not sharply regulated through the cell cycle and it is already present in early G1 cells. Notably, most Cln3 is retained bound to the ER in early G1 with the assistance of Whi3, an RNA-binding protein that binds the CLN3 mRNA, and it is released in late G1 by Ydj1, a J-chaperone that might transmit growth capacity information to the cell cycle machinery. However, little is known on the molecular mechanisms that retain the Cdc28-C1n3 complex in the cytoplasm and how do these mechanisms transmit information of cell size to coordinate cell proliferation with cell growth. As Cdc28 is important for proper retention of Cln3 at the ER, we hypothesized that mutations weakening interactions to unknown ER retention factors would cause premature release of the Cdc28-C1n3 complex and, hence, a smaller cell size. This thesis describes the isolation and characterization of a CDC28 quintuple mutant, which we refer to as CDC28wee, that causes premature entry into the cell cycle and a small cell size. Next we used isobaric tags for relative and absolute quantitation (iTRAQ) to identify direct interactors with lower affinities for mutant Cdc28wee, aiming at the identification of proteins with key regulatory roles in the retention mechanism. Among the identified proteins we found Sr13, a protein of unknown function, here renamed as Whi7. Here we show that Whi7 acts as an inhibitor of Start, associates to the ER and contributes to efficient retention of the Cln3 cyclin, thus preventing its unscheduled accumulation in the nucleus. Our results demonstrate that Whi7 acts in a positive feedback loop to release the G1 Cdk¬cyclin complex and trigger Start once a critical size has been reached, thus uncovering a key nonlinear mechanism at the earliest known events of cell cycle entry. In addition to Whi7 we also identified Whi8, renamed here as Whi8, which is an RNA-binding protein present in both stress granules (SGs) and P bodies (PBs) with unknown biological function. We have found that Whi8 interacts with Cdc28 in vivo, binds and colocalizes with the CLN3 mRNA, and interacts with Whi3 in an RNA-dependent manner. Whi8-deficient cells showed a smaller budding cell size while, on the other hand, overexpression of Whi8 increased the budding volume. Cells lacking Whi8 were not capable of accumulating the CLN3 mRNA in SGs under stress conditions, and Cln3 synthesis remained high under glucose and nitrogen starvation, two environmental stress conditions that dramatically decrease Cln3 levels in the cell. Whi8 accumulation in SGs depended on an intrinsically disordered domain (IDD) identified at C-terminus of Whi8 and specific PKA phophosites. Our results suggest that Whi8 acts under stress as a safeguard that limits the influx of newly synthesized Cln3 (and likely other proteins) into the cell cycle machinery, by trapping the CLN3 mRNA in mRNA granules. Thus, we have found a unique target for signaling pathways that directly links stress response and cell cycle entry

Brain tumor MRI medical images classification model based on CNN (BTMIC-CNN)

This research discusses a fully automatic brain tumour MRI medical images classification model that use Convolutional Neural Network (BTMIC-CNN). The proposed neural model adopted Design Science Research Methodology (DSRM) to classify MRI medical images from two datasets. One for binary classification task (contains tumorous and non-tumorous images). And the second for multiclass classification task (contains three types of brain tumor MRI medical images namely: Glioma, meningioma, and pituitary). The model's excellent performance was confirmed using the evaluation metrics and reported an overall accuracy of 99%. It outperforms existing methods in terms of classification accuracy and is expected to help radiologists and doctors accurately classify brain tumours’ images. This study contributes to goal three of the Sustainable Development Goals (SDGs), which involves excellent health and well-being

Brain tumor MRI medical images classification with data augmentation by transfer learning of VGG16

The ability to estimate conclusions without direct human input in healthcare systems via computer algorithms is known as Artificial intelligence (AI) in healthcare. Deep learning (DL) approaches are already being employed or exploited for healthcare purposes, and in the case of medical images analysis, DL paradigms opened a world of opportunities. This paper describes creating a DL model based on transfer learning of VGG16 that can correctly classify MRI images as either (tumorous) or (non-tumorous). In addition, the model employed data augmentation in order to balance the dataset and increase the number of images. The dataset comes from the brain tumour classification project, which contains publicly available tumorous and non-tumorous images. The result showed that the model performed better with the augmented dataset, with its validation accuracy reaching ~100 %

EEG-based emotion recognition while listening to Quran recitation compared with relaxing music using Valence-arousal model

Relaxation and calmness are two emotions that people always seek for. One popular method people used to do in order to reduce their level of tension and pressure is listening to some types of relaxing music. On the other hand, Quran is Allah’s words that are ultimately given to us human to benefit of. Although, Muslims are strongly believed that listening to Quran or reading it brings them to comfort, pleasure and confidence. Scientific evidence is still required to prove that scientifically. Human emotion can be recognized from voice, text, facial expression or body language. But those methods are susceptible to change and are not really accurate. Recently, electroencephalograms (EEG) allowed researchers to evoke the inner emotions. This paper aims to study human emotions while listening to Quran recitation compared with listening to relaxing music. To evoke emotions, some stimuli should be used; in this research we implemented International Affective Picture System (IAPS) database. And for the emotion classification technique we followed two-dimensional Arousal- Valence emotion model. Finally the emotion model was implemented to recognize four basic emotions Happy, Fear, Sad and Calm with an average accuracy of 76.81 %. The data collected while listening to Quran and music were tested and the result generally showed that both Quran and Music are classified more into positive valence

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Burnout among surgeons before and during the SARS-CoV-2 pandemic: an international survey

Background: SARS-CoV-2 pandemic has had many significant impacts within the surgical realm, and surgeons have been obligated to reconsider almost every aspect of daily clinical practice. Methods: This is a cross-sectional study reported in compliance with the CHERRIES guidelines and conducted through an online platform from June 14th to July 15th, 2020. The primary outcome was the burden of burnout during the pandemic indicated by the validated Shirom-Melamed Burnout Measure. Results: Nine hundred fifty-four surgeons completed the survey. The median length of practice was 10 years; 78.2% included were male with a median age of 37 years old, 39.5% were consultants, 68.9% were general surgeons, and 55.7% were affiliated with an academic institution. Overall, there was a significant increase in the mean burnout score during the pandemic; longer years of practice and older age were significantly associated with less burnout. There were significant reductions in the median number of outpatient visits, operated cases, on-call hours, emergency visits, and research work, so, 48.2% of respondents felt that the training resources were insufficient. The majority (81.3%) of respondents reported that their hospitals were included in the management of COVID-19, 66.5% felt their roles had been minimized; 41% were asked to assist in non-surgical medical practices, and 37.6% of respondents were included in COVID-19 management. Conclusions: There was a significant burnout among trainees. Almost all aspects of clinical and research activities were affected with a significant reduction in the volume of research, outpatient clinic visits, surgical procedures, on-call hours, and emergency cases hindering the training. Trial registration: The study was registered on clicaltrials.gov "NCT04433286" on 16/06/2020

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Molecular retention mechanisms of the G1 cyclin/Cdk complex in budding yeast

Peer Reviewe

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

[Background]: The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019.[Methods]: We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends.[Findings]: In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR.[Interpretation]: The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rheumatoid arthritis and upsurging new cases of other five IMIDs, respectively.The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The project funded by Scientific Research Fund of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (2022QN38).Peer reviewe